PBCLN-014

· Prolacta Bioscience

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBCLN-014, covering 2024-08-19 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation [Phase 2]

See pricing